What We're Reading: Page 300
Industry reads hand-picked by our editors
Jun 29, 2017
-
Nikkei Asian Review
Takeda chief confronts growing pains – and lack of growth – without old ally
-
Kaiser Health News
Seniors miss out on clinical trials
-
MIT Technology Review
Organoids proposed to screen patients for high-priced drugs
Jun 28, 2017
-
The Washington Post
Pharmaceutical giant rocked by ransomware attack
-
CNBC
Teva Pharmaceutical CEO says health-care is facing 'huge disruption'
-
Scientific American
Human Cell Atlas opens a new window to health and disease
Jun 27, 2017
Jun 26, 2017
-
The Wall Street Journal
How AI is transforming drug creation
-
The Irish Times
Pharma research firm APC has just the right medicine
-
Phys.org
How to train your drugs: from nanotherapeutics to nanobots
Jun 23, 2017
-
The New York Times
Insurers battle families over costly drug for fatal disease
-
EP Vantage
German Merck doubles down on dual-acting cancer agents
-
Bloomberg
Biotech stock rally may have legs
Jun 22, 2017
-
The New York Times
GSK wins $235 million from Teva in Coreg patent trial
-
EP Vantage
Only Bristol bucks big pharma’s drive for external reliance
-
Financial Times
Pharma recovers composure as price concerns ease
Jun 21, 2017
-
Chemical and Engineering News
U.S. Supreme Court gives pharma a product liability win
-
Reuters
Drugmaker Mylan gets boost from unlikely source: coal
-
Bloomberg Gadfly
So much for Trump going after pharma
Previous
